Results 261 to 267 of about 258,722 (267)

HI-6 in Man: Efficacy of the Oxime in Poisoning by Organophosphorus Insecticides

Human & Experimental Toxicology, 1991
The efficacy of the oxime HI-6 was studied as a treatment for organophosphorus poisoning. HI-6 was given four times daily as a single intramuscular injection of 500 mg accompanied by atropine and diazepam therapy. Oxime treatment was started on admission and continued for a minimum of 48 h and a maximum of 7 d.
R, Kusić, D, Jovanović, S, Randjelović, D, Joksović, V, Todorovic, B, Bosković, M, Jokanović, V, Vojvodić   +7 more
openaire   +2 more sources

Histopathological Changes in Gastrocnemius Muscles of Rabbits Injected with HI-6 in Saline

Drug and Chemical Toxicology, 1990
The gastrocnemius muscles of rabbits were injected with HI-6 in saline. Macroscopic and histopathological examinations of injection sites and regional lymph nodes revealed that HI-6 in saline produced muscle necrosis. Macroscopic examinations of muscles injected with a low dose of HI-6 (50 mg/kg) showed no lesions on Day 7.
C E, Connolley-Mendoza, T, Bhatti, K, Jericho   +2 more
openaire   +2 more sources

Hyaluronidase: Its effects on HI-6 dichloride and dimethanesulphonate pharmacokinetic profile in pigs

Toxicology Letters, 2013
Pigs were administered intramuscularly molar equivalents of HI-6 salts (HI-6 dichloride 10.71 mg/kg and HI-6 DMS 13.59 mg/kg) either with or without hyaluronidase (60 U/kg). Hyaluronidase is supposed to increase tissue permeability and diminishes discomfort caused by the intramuscular injection.
Jana Zdarova, Karasova, Michal, Pavlik, Jaroslav, Chladek, Daniel, Jun, Kamil, Kuca   +4 more
openaire   +2 more sources

Stability study of HI-6 dichloride in various anticholinergic formulations

Journal of Chromatography A, 1984
N D, Brown, R R, Gray, M G, Stermer-Cox, B P, Doctor, I, Hagedorn   +4 more
openaire   +2 more sources

Inhibicija acetilkolinesteraze i butirilkolinesteraze piridinijevim oksimima 2- PAM i HI-6

2005
Piridin-2-aldoksim-N-metilklorid (2-PAM) i 1- (2-hidroksiiminometil-1-piridinio)-3-(4- karbamoil-1-piridinio)-2-oksapropan diklorid (HI-6) su reverzibilni inhibitori acetilkolinesteraze (EC 3.1.1.7 ; AChE) i butirilkolinesteraze (EC 3.1.1.8 ; BChE).
openaire   +1 more source

TORQUATO TASSO, in his 6 Part., fol. 47

1940
openaire   +1 more source

Torquato Tasso. in his 6 Part. fol. 47

openaire   +1 more source